Acquiring Company
Sernova Biotherapeutics
Acquired Company
Seraxis
MarylandBiotechnologyHealth CareTherapeuticsManufacturingBiotechnologyHealth CareDescription
Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. have completed financing to support their merger, creating BetaNova Biotherapeutics, Inc. The merger will combine their resources to advance cell-replacement therapies for type 1 diabetes. Shareholders of both companies are expected to own approximately 50% of BetaNova upon completion. The merger is set to progress with upcoming clinical trials and manufacturing activities.
Fundz sees it the moment Sernova Biotherapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Seraxis?
Seraxis was acquired by Sernova Biotherapeutics. The deal was reported on October 5, 2026. Sernova Biotherapeutics is privately held and operates in Biotechnology.
When did Sernova Biotherapeutics acquire Seraxis?
Sernova Biotherapeutics's acquisition of Seraxis was reported on October 5, 2026. Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. have completed financing to support their merger, creating BetaNova Biotherapeutics, Inc. The merger will combine their resources to advance cell-replacement therapies for type 1 diabetes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Seraxis do?
Seraxis is a private biotechnology company launched in 2013. It focuses on developing innovative treatments for diabetes. The company specializes in stem cell-derived pancreatic islet cells and manufacturing operations. It is privately held, operating in Manufacturing, and is based in Maryland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.